Suppr超能文献

相似文献

1
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.
Int J Mol Sci. 2018 Oct 16;19(10):3198. doi: 10.3390/ijms19103198.
3
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.
Clin Cancer Res. 2014 May 1;20(9):2363-74. doi: 10.1158/1078-0432.CCR-13-2052. Epub 2014 Mar 11.
5
FLT3-TKD mutation in childhood acute myeloid leukemia.
Leukemia. 2003 May;17(5):883-6. doi: 10.1038/sj.leu.2402928.
6
FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development.
Cancer Sci. 2020 Feb;111(2):312-322. doi: 10.1111/cas.14274. Epub 2019 Dec 30.
7
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia.
J Hematol Oncol. 2021 Jul 3;14(1):105. doi: 10.1186/s13045-021-01098-y.
8
Therapeutic Vulnerabilities in -Mutant AML Unmasked by Palbociclib.
Int J Mol Sci. 2018 Dec 11;19(12):3987. doi: 10.3390/ijms19123987.
9
Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitors.
Biochem Pharmacol. 2021 Jan;183:114348. doi: 10.1016/j.bcp.2020.114348. Epub 2020 Nov 23.
10
[FLT3 Mutations in Acute Myeloid Leukemia].
Rinsho Byori. 2017 Jan;65(1):44-51.

引用本文的文献

1
Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications.
Research (Wash D C). 2025 Jun 21;8:0747. doi: 10.34133/research.0747. eCollection 2025.
2
Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia.
Cochrane Database Syst Rev. 2025 Apr 28;4(4):CD016090. doi: 10.1002/14651858.CD016090.
6
Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations.
ACS Pharmacol Transl Sci. 2024 Apr 11;7(5):1485-1506. doi: 10.1021/acsptsci.4c00071. eCollection 2024 May 10.
8
PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy.
Mol Cancer. 2023 Mar 30;22(1):62. doi: 10.1186/s12943-022-01707-5.
9
Emergence of (p190) in Acute Myeloid Leukemia Post-Gilteritinib Therapy.
Ann Lab Med. 2023 Jul 1;43(4):386-388. doi: 10.3343/alm.2023.43.4.386. Epub 2023 Feb 24.

本文引用的文献

1
Modification of Crocodile Spermatozoa Refutes the Tenet That Post-testicular Sperm Maturation Is Restricted To Mammals.
Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S58-S76. doi: 10.1074/mcp.RA118.000904. Epub 2018 Aug 2.
2
Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid Leukemia.
Am J Hematol. 2018 Sep;93(9):1136-1141. doi: 10.1002/ajh.25198. Epub 2018 Aug 31.
3
Somatic mutations precede acute myeloid leukemia years before diagnosis.
Nat Med. 2018 Jul;24(7):1015-1023. doi: 10.1038/s41591-018-0081-z. Epub 2018 Jul 9.
4
Prediction of acute myeloid leukaemia risk in healthy individuals.
Nature. 2018 Jul;559(7714):400-404. doi: 10.1038/s41586-018-0317-6. Epub 2018 Jul 9.
6
Insight into the inhibitor discrimination by FLT3 F691L.
Chem Biol Drug Des. 2018 May;91(5):1056-1064. doi: 10.1111/cbdd.13169. Epub 2018 Feb 12.
7
Determinants and clinical implications of chromosomal instability in cancer.
Nat Rev Clin Oncol. 2018 Mar;15(3):139-150. doi: 10.1038/nrclinonc.2017.198. Epub 2018 Jan 3.
8
The target landscape of clinical kinase drugs.
Science. 2017 Dec 1;358(6367). doi: 10.1126/science.aan4368.
9
Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.
Front Oncol. 2017 Nov 6;7:263. doi: 10.3389/fonc.2017.00263. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验